SINGAPORE, April 25, 2025 /PRNewswire/ -- 51Talk Online Education Group ("51Talk" or the "Company") (NYSE American: COE), a global online education platform with core expertise in English education, announced  that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2024 with the Securities and Exchange Commission ("SEC") on April 25, 2025. The annual report can be accessed on the Company's investor relations website at http://ir.51talk.com/ as well as the SEC's website at http://www.sec.gov. The Company will provide a hard copy of its annual report containing the audited consolidated financial statements for the fiscal year ended December 31, 2024, free of charge

Marti Technologies, Inc. ("Marti") (NYSE:MRT), Türkiye's leading mobility super app, will announce its full year 2024 financial and operational results before the U.S. markets open on Tuesday, April 29, 2025. Conference Call and Webcast Details Marti's management will host an analyst and investor conference call and live webcast to discuss its financial results at 3:30 p.m. Istanbul / 1:30 p.m. London / 8:30 a.m. New York time on Tuesday, April 29, 2025. Live webcast can be accessed via: https://event.choruscall.com/mediaframe/webcast.html?webcastid=KyUxGfY3 Participant Dial-In: 877-485-3103 / +1 201-689-8890 A replay will be available on the Marti Investor Relations website https://i

SAN DIEGO, April 25, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (NASDAQ:SKYE) ("Skye"), a clinical-stage biopharmaceutical company focused on unlocking new therapeutic pathways for metabolic health, today announced that on April 23, 2025, the Board of Directors granted a non-qualified stock option award to purchase 19,000 shares of its common stock to one new non-executive employee under the Company's Amended and Restated 2024 Inducement Equity Incentive Plan (the "2024 Inducement Plan"). The stock options were granted as an inducement material to the employee entering into employment with Skye in accordance with Nasdaq Listing Rule 5635(c)(4). The 2024 Inducement Plan is used exclu

TORONTO, April 25, 2025 /PRNewswire/ - Agnico Eagle Mines Limited (NYSE:AEM) (TSX:AEM) ("Agnico Eagle") today announced that, at the annual and special meeting of shareholders held on April 25, 2025 (the "Meeting"), the eleven candidates listed in the management information circular dated March 24, 2025 were duly elected as directors of Agnico Eagle. Detailed results of the vote are set out below: Nominee Votes For Votes Withheld Total Votes Cast Percentage of Votes For Percentage of Votes Withheld Leona Aglukkaq 371,502,868 7,658,869 379,161,737 97.98 % 2.02 % Ammar Al-Joundi 373,630,157 5,531,581 379,161,738 98.54 % 1.46 % Sean Boyd 360,232,856 18,928,881 379,161,737 95.01 % 4.99 % Ma

Morgan Stanley upgraded Saia from Underweight to Equal-Weight

BMO Capital Markets downgraded Saia from Outperform to Market Perform and set a new price target of $285.00 from $455.00 previously

BofA Securities downgraded Adecoagro S.A. from Buy to Underperform and set a new price target of $10.80 from $12.00 previously

BofA Securities reiterated coverage of Monster Beverage with a rating of Buy and set a new price target of $66.00 from $57.00 previously

4 - BioCardia, Inc. (0000925741) (Issuer)

4 - BioCardia, Inc. (0000925741) (Issuer)

4 - BioCardia, Inc. (0000925741) (Issuer)

4 - BioCardia, Inc. (0000925741) (Issuer)

4 - BioCardia, Inc. (0000925741) (Issuer)

4 - BioCardia, Inc. (0000925741) (Issuer)

4 - BioCardia, Inc. (0000925741) (Issuer)

4 - BioCardia, Inc. (0000925741) (Issuer)

SCHEDULE 13G - Hess Midstream LP (0001789832) (Subject)

SCHEDULE 13G/A - BlackRock, Inc. (0002012383) (Filed by)

SCHEDULE 13G/A - BlackRock, Inc. (0002012383) (Filed by)

SCHEDULE 13G/A - BlackRock, Inc. (0002012383) (Filed by)

For Immediate Release: March 28, 2025 Today, the U.S. Food and Drug Administration approved Qfitlia (fitusiran) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients 12 years of age and older with hemophilia A or hemophilia B, with or without factor VIII or IX inhibitors (neutralizing antibodies).“Today’s approval of Qfitlia is significant for patients wi

For Immediate Release: March 11, 2025 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:Today, the FDA published a General Correspondence Letter issued to Mid-Link Technology Testing Co., Ltd. The FDA is vigilant in ensuring data submitted to the FDA can be relied upon to assess the effectiveness, safety, or risk of a device. The FDA has noted an incr

For Immediate Release: February 28, 2025 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:On Thursday, the FDA approved Odactra to include use in individuals 5 through 11 years of age to treat house dust mite induced nasal inflammation (allergic rhinitis), with or without eye inflammation (conjunctivitis). Odactra is an allergen extract immunotherapy

For Immediate Release: February 21, 2025 Today, the U.S. Food and Drug Administration approved Ctexli (chenodiol) for the treatment of cerebrotendinous xanthomatosis (CTX) in adults. Ctexli is the first FDA-approved drug to treat CTX, a very rare lipid storage disease.“The FDA is dedicated to supporting new drug development for rare diseases including very rare metabolic diseases like cerebrotendinous xanthomato

Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, today announced the election of Lynda Cloud to its Board of Directors, effective April 23, 2025. This appointment reflects Herbalife's continued commitment to innovation, digital transformation, and personalized wellness. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250425107883/en/Herbalife Welcomes Lynda Cloud to the Board of Directors Lynda Cloud's decades of leadership across education, technology, and health sectors make her uniquely equipped to support Herbalife's next chapter. Her deep expertise in digital learning, consumer experie

Dr. Daniel Greenstein Brings Extensive Experience in Higher Education Strategy and Innovation to the Board Mr. Gary Millerchip Brings Decades of Experience in Finance, Retail Banking, and Corporate Strategy to the Board Sallie Mae® (NASDAQ:SLM), formally SLM Corporation, today announced the appointments of Dr. Daniel Greenstein and Mr. Gary Millerchip to its board of directors, effective April 23, 2025. Dr. Greenstein brings decades of experience in higher education strategy, innovation, and transformation to the Board. He currently serves as Managing Director, Higher Education at Baker Tilly (US), a position he has held since November 2024. Before joining Baker Tilly (US), he served as

ATHENS, Greece, April 25, 2025 (GLOBE NEWSWIRE) -- Okeanis Eco Tankers Corp. (the "Company" or "OET") (NYSE:ECO), announced today that it has scheduled its Annual Meeting of Shareholders for May 30, 2025, at 11:00 a.m. Greek time (the "Annual Meeting"). The record date for determining shareholders entitled to participate at the Annual Meeting is April 22, 2025. The business of the Annual Meeting is to elect eight directors to serve until the next annual meeting of shareholders or until their successors are elected and qualified, and to ratify the appointment of Deloitte Certified Public Accountants S.A. as the Company's independent registered public accounting firm for the fiscal year endi

Kettle, part of the Code and Theory Network, Stagwell's digital transformation network, is scaling as the go-to digital partner for leading consumer brands.  NEW YORK, April 25, 2025 /PRNewswire/ -- Kettle, the digital creative agency behind standout work for Apple, T-Mobile, Warby Parker and e.l.f. Beauty is entering a bold new chapter powered by rapid growth, creative reinvention, and a leadership structure re-engineered for what's next. At the center of this evolution is the promotion of Camille Imbert to its first-ever Chief Creative Officer (CCO) and Jess Mireau to its inaugural Chief Product Officer (CPO). Together with CEO Lauren Kushner, they form an all-women C-suite.

Marti Technologies, Inc. ("Marti") (NYSE:MRT), Türkiye's leading mobility super app, will announce its full year 2024 financial and operational results before the U.S. markets open on Tuesday, April 29, 2025. Conference Call and Webcast Details Marti's management will host an analyst and investor conference call and live webcast to discuss its financial results at 3:30 p.m. Istanbul / 1:30 p.m. London / 8:30 a.m. New York time on Tuesday, April 29, 2025. Live webcast can be accessed via: https://event.choruscall.com/mediaframe/webcast.html?webcastid=KyUxGfY3 Participant Dial-In: 877-485-3103 / +1 201-689-8890 A replay will be available on the Marti Investor Relations website https://i

TORONTO, April 25, 2025 /PRNewswire/ - Agnico Eagle Mines Limited (NYSE:AEM) (TSX:AEM) ("Agnico Eagle") today announced that, at the annual and special meeting of shareholders held on April 25, 2025 (the "Meeting"), the eleven candidates listed in the management information circular dated March 24, 2025 were duly elected as directors of Agnico Eagle. Detailed results of the vote are set out below: Nominee Votes For Votes Withheld Total Votes Cast Percentage of Votes For Percentage of Votes Withheld Leona Aglukkaq 371,502,868 7,658,869 379,161,737 97.98 % 2.02 % Ammar Al-Joundi 373,630,157 5,531,581 379,161,738 98.54 % 1.46 % Sean Boyd 360,232,856 18,928,881 379,161,737 95.01 % 4.99 % Ma

CHICAGO, April 25, 2025 /PRNewswire/ -- Kellanova (NYSE:K) today announced that its Board of Directors declared a dividend of $0.57 per share on the common stock of Kellanova, payable on June 13, 2025, to shareowners of record at the close of business on June 2, 2025. The ex-dividend date is June 2, 2025. This is the 402nd dividend that Kellanova, previously Kellogg Company, has paid to owners of common stock since 1925.  About Kellanova Kellanova (NYSE: K) is a leader in global snacking, international cereal and noodles, and North America frozen foods with a legacy stretching

Compass Minerals (NYSE:CMP), a leading global provider of essential minerals, will release its second-quarter fiscal 2025 results Wednesday, May 7, 2025, after the markets close. The company's president and CEO, Edward C. Dowling Jr., and CFO, Peter Fjellman, will discuss these results on a conference call on Thursday, May 8, 2025, at 9:30 a.m. ET. Access to the conference call will be available via webcast at investors.compassminerals.com or by dialing 1-800-715-9871. Callers must provide the conference ID number 7896827. Outside of the U.S. and Canada, callers may dial 1-646-307-1963. An audio replay of the conference call will be available on the company's website. About Compass Minera

SC 13D/A - ALLIANCEBERNSTEIN HOLDING L.P. (0000825313) (Subject)

SC 13D/A - CVR ENERGY INC (0001376139) (Subject)

SC 13D/A - INCOME OPPORTUNITY REALTY INVESTORS INC /TX/ (0000949961) (Subject)

SC 13D/A - Arcus Biosciences, Inc. (0001724521) (Subject)

Recently, on July 4, 2024, a significant insider purchase was recorded at Allied Gaming & Entertainment Inc. as Large owner Choi Roy bought $456,750 worth of shares (360,000 units at $1.27), increasing direct ownership by 14% to 2,871,822 units (SEC Form 4). This purchase is notable for the size of the transaction and the percentage increase in direct ownership, indicating a strong belief in the company's future prospects. Insider purchases are generally viewed positively by investors as they signal confidence from those with intimate knowledge of the company's operations. Examining other recent insider transactions at Allied Gaming & Entertainment Inc., we notice a few patterns worth explo

Recently, on June 25, 2024, Director Romano Kelly A bought $100,051 worth of shares in Athira Pharma Inc. This transaction involved acquiring 42,400 units at $2.36 per share, resulting in a significant increase in direct ownership by 111% to 80,715 units. The purchase was disclosed in the SEC Form 4 filing. Insider buying is often considered a bullish signal as insiders may have insights into the company's future performance. It's essential to analyze this insider purchase in conjunction with previous insider transactions to identify any patterns or trends. Taking into account the information from the SEC filings, several other insiders at Athira Pharma Inc. have also been active in the sto

Recently, on June 26, 2024, Director Juda Scott bought $36,350 worth of shares (5,000 units at $7.27) (SEC Form 4) in INmune Bio Inc. This insider purchase is significant as it indicates confidence from someone within the company towards its future growth prospects. It's interesting to note that this purchase by Juda Scott follows a series of transactions by other insiders in the company. For example, Moss David J bought $149,993 worth of shares (18,028 units at $8.32) on April 24, 2024, increasing direct ownership by 1% to 1,268,179 units. This demonstrates a consistent trend of insider buying within the organization. Looking back at previous transactions, on May 16, 2024, several key ins

Monopar Therapeutics Inc. has recently seen notable insider activity, with Chief Operating Officer Cittadine Andrew purchasing $25,574 worth of shares on June 21st, 2024. This purchase, comprising 32,508 units at $0.79, increased Cittadine's direct ownership by 21% to 186,132 units as reported in the SEC Form 4. When analyzing this transaction alongside other recent insider activities within the company, interesting patterns and trends start to emerge. Looking back, Cittadine Andrew has been consistently adding to his position in Monopar Therapeutics Inc. over the past few months, showcasing a strong conviction in the company's future prospects. On May 31st, Cittadine Andrew made a substan